Gainers
- Avidity Biosciences (NASDAQ:RNA) shares rose 24.5% to $36.0 during Wednesday's pre-market session. The company's market cap stands at $3.4 billion.
- Molecular Partners (NASDAQ:MOLN) shares moved upwards by 18.43% to $5.91. The market value of their outstanding shares is at $196.1 million.
- Longeveron (NASDAQ:LGVN) shares increased by 15.84% to $0.95. The company's market cap stands at $6.0 million.
- TRACON Pharma (NASDAQ:TCON) shares increased by 15.74% to $1.25. The market value of their outstanding shares is at $3.3 million.
- Oramed Pharmaceuticals (NASDAQ:ORMP) stock moved upwards by 14.49% to $2.37. The market value of their outstanding shares is at $96.2 million.
- NovaBay Pharmaceuticals (AMEX:NBY) stock rose 12.72% to $3.1. The market value of their outstanding shares is at $3.5 million.
Losers
- ThermoGenesis Holdings (NASDAQ:THMO) shares decreased by 40.5% to $0.33 during Wednesday's pre-market session. The company's market cap stands at $2.6 million.
- Calidi Biotherapeutics (AMEX:CLDI) shares fell 11.86% to $0.24. The market value of their outstanding shares is at $15.2 million.
- Streamline Health Solns (NASDAQ:STRM) shares decreased by 10.94% to $0.57. The market value of their outstanding shares is at $35.4 million. As per the news, the Q1 earnings report came out yesterday.
- Tevogen Bio Holdings (NASDAQ:TVGN) shares decreased by 8.28% to $0.8. The company's market cap stands at $132.8 million.
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares decreased by 8.11% to $1.7. The market value of their outstanding shares is at $2.4 million.
- Bright Green (NASDAQ:BGXX) stock fell 7.91% to $0.28. The market value of their outstanding shares is at $53.3 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
